SCHEMBL29981298

SCHEMBL29981298

CC(C)C(O)c1ccnc(-c2ccc3c(c2)CCC=N3)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30470204 0.71 MAPT (0.50) —
SCHEMBL24367664 0.71 MAPT (0.50) —
SCHEMBL24718998 0.68 CYP3A4 (0.46) —
SCHEMBL29672433 0.62 KDM1A (0.47) —
SCHEMBL29672436 0.62 KDM1A (0.47) —
SCHEMBL15341900 0.61 WDR5 (0.49) —
SCHEMBL31556406 0.61 FAAH (0.39) —
SCHEMBL24367658 0.59 RECQL (0.42) —
SCHEMBL22780705 0.59 — —
SCHEMBL20896958 0.59 HTR2A (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240279219-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-08-22 — — US disclosed
US-20230113778-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2023-04-13 — — US disclosed
US-11492350-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2022-11-08 — — US disclosed
Send feedback